Displaying drugs 651 - 675 of 819 in total
4-phospho-D-erythronic acid
Experimental
Carboxylic PRPP
Experimental
Amrubicin
Amrubicin is a third-generation synthetic anthracycline currently in development for the treatment of small cell lung cancer. Pharmion licensed the rights to Amrubicin in November 2006. In 2002, Amrubicin was approved and launched for sale in Japan based on Phase 2 efficacy data in both SCLC and NSCLC. Since January...
Investigational
PAS219
Experimental
4-hydroxyphenacyl coenzyme A
Experimental
(S)-4-bromo-3-hydroxy-3-methylbutyl diphosphate
Experimental
(R)-carnitinyl-CoA betaine
Experimental
CoA-S-acetyl 5-bromotryptamine
Experimental
Succinyl-Coenzyme A
Experimental
(R)-methylmalonyl-CoA
Experimental
Malonyl-CoA
A coenzyme A derivative which plays a key role in the fatty acid synthesis in the cytoplasmic and microsomal systems.
Experimental
6-phospho-D-gluconic acid
Experimental
Nicotinamide adenine dinucleotide cyclohexanone
Experimental
Methacrylyl-Coenzyme A
Experimental
Propanoyl-CoA
Experimental
CoA-s-acetyl tryptamine
Experimental
3-Hydroxybutyryl-Coenzyme A
Experimental
6-hydroxy-FAD
Experimental
GDP-alpha-D-mannuronic acid
Experimental
Cpad
Experimental
Adenylosuccinic acid
Experimental
2'-fluoro-2'-deoxyuridine 3'-monophosphate
Experimental
2-Dimethylamino-Ethyl-Diphosphate
Experimental
Nitromethyldethia coenzyme A
Experimental
Displaying drugs 651 - 675 of 819 in total